Neurology

>

Latest News

FDA expands use of eculizumab to patients 6 years and up with generalized myasthenia gravis | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA expands use of eculizumab to patients 6 years and up with generalized myasthenia gravis

March 4th 2025

First approved for PNH in 2007, the monoclonal antibody is now the first and only treatment for pediatric patients living with gMG.

Image Credit: © Araki Illustrations - stock.adobe.com
FDA accepts new drug application for vatiquinone to treat Friedreich's ataxia

February 19th 2025

Weekly review: Several key FDA approvals, new puzzler case, and more | Image Credit: © Artur - © Artur - stock.adobe.com.
Weekly review: Several key FDA approvals, new puzzler case, and more

February 17th 2025

FDA approves non-invasive risdiplam tablet for spinal muscular atrophy | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves non-invasive risdiplam tablet for spinal muscular atrophy

February 12th 2025

Positive data reported for Trappsol Cyclo in patients 3 years and under with NPC1 | Image Credit: © ธนากร บัวพรหม - © ธนากร บัวพรหม - stock.adobe.com.
Positive data reported for Trappsol Cyclo in patients 3 years and under with NPC1

February 7th 2025

Latest CME Events & Activities

A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology

View More

Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age

View More

Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

<1
...
34567
© 2025 MJH Life Sciences

All rights reserved.